Evidence map›Paper›PMID 21900486›Full record

ArticleThe Journal of infectious diseases2011

LPLUNC1 modulates innate immune responses to Vibrio cholerae.

Ok S Shin, Taher Uddin, Robert Citorik, Jennifer P Wang, Patricia Della Pelle, Richard L Kradin, Colin D Bingle, Lynne Bingle, Andrew Camilli, Taufiqur R Bhuiyan and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Inflammation induced by the new lineage ofFrontiers in immunology · 2025
    Article
  3. Article
  4. Article
  5. Intense light-elicited alveolar type 2-specific circadian PER2 protects from bacterial lung injury via BPIFB1.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. mSphere · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Ok S ShinDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
Taher Uddin
Robert Citorik
Jennifer P Wang
Patricia Della Pelle
Richard L Kradin
Colin D Bingle
Lynne Bingle
Andrew Camilli
Taufiqur R Bhuiyan
Tahmina Shirin
Edward T Ryan
Stephen B Calderwood
Robert W Finberg
Firdausi Qadri
Regina C Larocque
Jason B Harris
Office of Infectious Diseases · USInternational Centre for Diarrhoeal Disease Research · BDMassachusetts General Hospital · USUniversity of Massachusetts Chan Medical School · USHarvard University · USInstitute of Infection and Immunity · CATufts University · USUniversity of Sheffield · GB

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine developmentU01AI077883 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2008 to 2012
$5.6M
The role of TcpA in cholera immunity and vaccinationK01TW007409 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2005 to 2011
$867k
Identification of human gene polymorphisms related to Vibrio cholerae infectionK01TW007144 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI LAROCQUE, REGINA C · 2004 to 2009
$617k
Mucosal immune response to oral cholera vaccine Peru 15R03AI063079 · NIAID · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI QADRI, FIRDAUSI · 2005 to 2007
$158k
FIC NIH HHS K01 TW007144FIC NIH HHS K01 TW007409FIC NIH HHS K01 TW07144FIC NIH HHS K01 TW07409Howard Hughes Medical InstituteNIAID NIH HHS R03 AI063079NIAID NIH HHS U01 AI058935NIAID NIH HHS U01 AI077883NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

backgroundRecent studies demonstrate that long palate, lung, and nasal epithelium clone 1 protein (LPLUNC1) is involved in immune responses to Vibrio cholerae, and that variations in the LPLUNC1 promoter influence susceptibility to severe cholera in humans. However, no functional role for LPLUNC1 has been identified.

methodsWe investigated the role of LPLUNC1 in immune responses to V. cholerae, assessing its affect on bacterial growth and killing and on innate inflammatory responses to bacterial outer membrane components, including purified lipopolysaccharide (LPS) and outer membrane vesicles. We performed immunostaining for LPLUNC1 in duodenal biopsies from cholera patients and uninfected controls.

resultsLPLUNC1 decreased proinflammatory innate immune responses to V. cholerae and Escherichia coli LPS. The effect of LPLUNC1 was dose-dependent and occurred in a TLR4-dependent manner. LPLUNC1 did not affect lipoprotein-mediated TLR2 activation. Immunostaining demonstrated expression of LPLUNC1 in Paneth cells in cholera patients and controls.

conclusionsOur results demonstrate that LPLUNC1 is expressed in Paneth cells and likely plays a role in modulating host inflammatory responses to V. cholerae infection. Attenuation of innate immune responses to LPS by LPLUNC1 may have implications for the maintenance of immune homeostasis in the intestine.

Indexed as

Immunity, InnateAutoantigensDuodenumEscherichia coliFatty Acid-Binding ProteinsHumansImmunohistochemistryLipopolysaccharidesPaneth CellsProteinsVibrio choleraeAutoantigensBPIFB1 protein, humanFatty Acid-Binding ProteinsLipopolysaccharidesProteins

Identifiers

PMID21900486
PMCPMC3182310
OpenAlexW2162340533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.